{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:24:23Z","timestamp":1770459863349,"version":"3.49.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Optic neuritis is (ON) is believed to be an immune-mediated disease; however, the association between optic neuritis and autoimmune diseases remains unclear. This study aimed to identify the incidence rate and adjusted hazard ratio (aHR) of autoimmune diseases in patients with optic neuritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This nationwide, population-based, retrospective cohort study collected patients\u2019 data between 1999 and 2013 from the National Health Insurance Research Database in Taiwan. A total of 9,235 patients were included. Using 1:4 propensity scoring, 1,847 patients were enrolled in the optic neuritis group and 7,388 in the non-optic neuritis group according to age, sex, comorbidities, and corticosteroid use. Follow-up was started from the index date and the endpoint was a diagnosis of new-onset autoimmune diseases including, myasthenia gravis (MG), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and ankylosing spondylitis (AS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Kaplan-Meier curves depicted that patients with optic neuritis had a higher cumulative incidence of autoimmune diseases than patients without optic neuritis. Cox proportional hazard regression showed that patients with optic neuritis were at a high risk of autoimmune diseases (aHR: 1.40; 95% C.I., 1.05\u20131.87), including MG (aHR: 4.16, 95% C.I.: 1.33\u201312.94), SLE (aHR: 3.33, 95% C.I.: 1.24\u20138.97), and AS (aHR: 2.86, 95% C.I.: 1.54\u20135.31). Subgroup analysis provided that patients with optic neuritis aged below 65 years (aHR: 1.42, 95% C.I.: 1.03\u20131.96) or who were females (aHR: 1.59, 95% C.I.: 1.11\u20132.27) had a significantly increased risk of autoimmune diseases compared to respective controls. The use of corticosteroids reduced the risk of autoimmune diseases in patients with optic neuritis (aHR for corticosteroids non-users: 1.46, 95% C.I.: 1.03\u20132.07).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with optic neuritis presented with a high risk of autoimmune diseases such as MG, SLE, and AS, especially patients with optic neuritis who were young or females. Corticosteroids attenuated the link between optic neuritis and subsequent autoimmune diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.903608","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T04:50:33Z","timestamp":1655095833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Kevin Sheng-Kai","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hsun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ophtha.2019.09.032","article-title":"Population-based incidence of pediatric and adult optic neuritis and the risk of multiple sclerosis.","volume":"127","author":"Lee","year":"2020","journal-title":"Ophthalmology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease.","volume":"77","author":"Braithwaite","year":"2020","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116554","article-title":"Incidence of optic neuritis in Korean children and adolescents: a nationwide survey and national registry analysis.","volume":"408","author":"Choi","year":"2020","journal-title":"J Neurol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jneuroim.2005.02.002","article-title":"Systemic T-cell activation in acute clinically isolated optic neuritis.","volume":"162","author":"Roed","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases.","volume":"345","author":"Davidson","year":"2001","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102468","article-title":"Estrogen, estrogen-like molecules and autoimmune diseases.","volume":"19","author":"Merrheim","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10384-018-0561-1","article-title":"Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.","volume":"62","author":"Kezuka","year":"2018","journal-title":"Jpn J Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: a review and proposed protocol.","volume":"10","author":"Petzold","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.540156","article-title":"AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis.","volume":"11","author":"Filippatou","year":"2020","journal-title":"Front Neurol."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis.","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus.","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5312\/wjo.v2.i12.07","article-title":"Classification criteria for spondyloarthropathies.","volume":"2","author":"Akgul","year":"2011","journal-title":"World J Orthop."},{"key":"B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaut.2014.01.015","article-title":"The classification and diagnostic criteria of ankylosing spondylitis.","author":"Raychaudhuri","year":"2014","journal-title":"J Autoimmun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study.","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/M21-1499","article-title":"Performance of the European Society of Cardiology 0\/1-Hour, 0\/2-hour, and 0\/3-hour algorithms for rapid triage of acute myocardial infarction.","volume":"175","author":"Chiang","year":"2022","journal-title":"Ann Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/00220345211037220","article-title":"Dementia and the risk of periodontitis: a population-based cohort study.","volume":"101","author":"Ma","year":"2022","journal-title":"J Dent Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/JPER.21-0256","article-title":"Fibromyalgia and periodontitis: bidirectional associations in population-based 15-year retrospective cohorts.","author":"Ma","year":"2021","journal-title":"J Periodontol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/JPER.21-0215","article-title":"Tonsillectomy as a risk factor of periodontitis: a population-based cohort study.","author":"Ma","year":"2021","journal-title":"J Periodontol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050699","article-title":"Human papillomavirus infection and the risk of erectile dysfunction: a nationwide population-based matched cohort study.","volume":"12","author":"Juang","year":"2022","journal-title":"J Pers Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ejo\/cjab050","article-title":"Patients with juvenile idiopathic arthritis are at increased risk for obstructive sleep apnoea: a population-based cohort study.","volume":"44","author":"Ma","year":"2022","journal-title":"Eur J Orthod."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14115","article-title":"Onset of oral lichen planus following dental treatments: a nested case-control study.","author":"Ma","year":"2021","journal-title":"Oral Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e20632","DOI":"10.1097\/MD.0000000000020632","article-title":"Relationship between Helicobacter pylori infection and psoriasis: a nationwide population-based longitudinal cohort study.","volume":"99","author":"Wu","year":"2020","journal-title":"Medicine."},{"key":"B24","doi-asserted-by":"crossref","first-page":"e0238242","DOI":"10.1371\/journal.pone.0238242","article-title":"Impact of tonsillectomy on irritable bowel syndrome: a nationwide population-based cohort study.","volume":"15","author":"Wu","year":"2020","journal-title":"PLoS One."},{"key":"B25","article-title":"Increased risk of temporomandibular joint disorders and craniofacial deformities in patients with juvenile idiopathic arthritis: a population-based cohort study.","author":"Ma","year":"","journal-title":"Int J Oral Maxillofac Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/IIO.0000000000000278","article-title":"Demyelinating optic neuritis and its subtypes.","volume":"59","author":"Levin","year":"2019","journal-title":"Int Ophthalmol Clin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus."},{"key":"B28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.mayocp.2019.09.012","article-title":"Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis.","volume":"95","author":"Nusbaum","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus.","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"B30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40264-020-01031-1","article-title":"Incidence rates of autoimmune diseases in european healthcare databases: a contribution of the ADVANCE Project.","volume":"44","author":"Willame","year":"2021","journal-title":"Drug Saf."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4806","article-title":"Systemic lupus erythematosus presenting as optic neuropathy: a case report.","volume":"11","author":"Zahid","year":"2019","journal-title":"Cureus."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.","volume":"37","author":"Hunter","year":"2017","journal-title":"Rheumatol Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/art.40192","article-title":"The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan Lupus Surveillance Program.","volume":"69","author":"Izmirly","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence.","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States.","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamadermatol.2019.0721","article-title":"Prevalence of advanced liver fibrosis in patients with severe psoriasis.","volume":"155","author":"Maybury","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jid.2017.10.024","article-title":"Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study.","volume":"138","author":"Ogdie","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/eye.2016.253","article-title":"Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions.","volume":"31","author":"Lee","year":"2017","journal-title":"Eye."},{"key":"B40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3760\/cma.j.issn.0412-4081.2019.03.005","article-title":"[Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].","volume":"55","author":"Song","year":"2019","journal-title":"Zhonghua Yan Ke Za Zhi."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.","volume":"102","author":"Zhao","year":"2018","journal-title":"Br J Ophthalmol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1172\/JCI16039","article-title":"Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.","volume":"112","author":"Jambou","year":"2003","journal-title":"J Clin Invest."},{"key":"B43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jclinepi.2020.08.016","article-title":"Integrating travel history via big data analytics under universal healthcare framework for disease control and prevention in the COVID-19 pandemic.","volume":"130","author":"Ma","year":"2021","journal-title":"J Clin Epidemiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijsu.2020.05.091","article-title":"Big Data-driven personal protective equipment stockpiling framework under universal healthcare for disease control and prevention in the COVID-19 Era.","volume":"79","author":"Ma","year":"2020","journal-title":"Int J Surg."},{"key":"B45","doi-asserted-by":"crossref","first-page":"p. 313","DOI":"10.1016\/B978-0-323-91907-4.00023-6","article-title":"Screening programs incorporating big data analytics.","author":"Ma","year":"2022","journal-title":"Big Data Analytics for Healthcare: Datasets, Techniques, Life Cycles, Management, and Applications."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.903608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:05:07Z","timestamp":1675814707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.903608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":45,"alternative-id":["10.3389\/fmed.2022.903608"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.903608","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"article-number":"903608"}}